StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Establishes On-Site Clinic

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Oct 07, 2021 10:45am

153 Views

Post# 33979709

RE:RE:RE:RE:RE:RE:Establishes On-Site Clinic

I think he will be back. 6-9 month delay as they had to get the Care deal in place and now rolling out D to C and B to B. Multiple clinic locations, Quest, Phlebfinders.

Another example:

Stage's recent posts on LinkedIn was liked by the founder of My One Medical Source. They connect patients with collection sites and labs. Just another partner able to promote Aristotle.

You can see the reach expanding. It was disappointing that the roll out was not well communicated and the D to C was delayed but many of the pieces are coming together.